27.00
+1.40
+(5.47%)
As of 8:15:04 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 68.93M | 70.66M | 285.1M | 303.06M |
Low Estimate | 68.3M | 70.5M | 284.89M | 299.91M |
High Estimate | 69.56M | 70.82M | 285.3M | 306.2M |
Year Ago Sales | 61.43M | 64.04M | 250.46M | 285.1M |
Sales Growth (year/est) | 12.21% | 10.33% | 13.83% | 6.30% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
XCP1.F | -- | -- | -- | -- |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
Maintains | Piper Sandler: Overweight to Overweight | 8/1/2024 |
Maintains | Piper Sandler: Overweight to Overweight | 2/1/2024 |
Downgrade | Raymond James: Outperform to Market Perform | 10/6/2022 |
Maintains | Raymond James: Outperform | 7/7/2022 |
Maintains | Raymond James: Outperform | 1/27/2022 |
Upgrade | Raymond James: Market Perform to Outperform | 3/11/2021 |